Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VCST .02 HUGE,MANTA shows Annual Revenues of $12,140,697.00 and Employs a staff of approximately 94.
DOLV projected annual revenue of $2.3 billion for new electric vehicle company. Some starter DD:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135042079
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135031019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134929257
VCST .014 7m Float, $320k PROFIT!!
VCST .014 10k left, Millions Bidding, 7m FLOAT
$DATI - Veztinc, talks DJ Khaled & Bruno Mars, present the #blockchain music app #VEZT on #CHEDDARtv - #NYSE https://finance.yahoo.com/news/digital-arts-media-network-first-225424590.html
POTN August Numbers looking good imo http://marijuanastocks.com/potnetwork-holding-inc-potn-19/
DOLV back to green -- ridiculously resilient!!! Symbol change could come as soon as next week!
Holding for dollars...
RAKR today's chart wow! Buy on the dips!
$SANP
Breakaway Gap will form today if 16/17s hold
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=135383065
APGI QB current - 5.8 mill assets - 1.9 net sales- last 10q
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12253215
70 mill float - 35 mill owned by insiders
$PUFXF owns a majority interest in PUF Ventures, Australia
Which is a private company with a purchase option on 27-hectares of land near the town of Casino, New South Wales . PVA is constructing a one million-square-foot greenhouse operation with large scale manufacturing and processing facilities for the cultivation, harvesting, processing of medical cannabis and associated products in Australia.
https://finance.yahoo.com/news/puf-ventures-build-1-million-070100429.html
$PSID ENG has delivered more than 1,500 specialty vehicles to customers around the globe, including more than 400 mobile laboratories, 600 broadcast news vehicles, and more than 400 vehicles for cellular, RF, infrared, utilities, and other applications. In June 2017, PositiveID sold a 49.8% equity interest in ENG for approximately $1.5 million to a strategic partner to help grow the worldwide lab business.
https://finance.yahoo.com/news/positiveid-e-n-g-mobile-120000995.html
$ABVG 0003 Huge News Pending finalizing Purchase of Jawea Ice Cream!! Mult-Million Dollars Revenues!
Over 500 million on The bid
$PSID ENG, which has a video on its website showcasing its capabilities, designs and builds mobile laboratories, wireless support vehicles (cell-on-wheels and cell-on-light-trucks), radio frequency (“RF”) test platforms, custom vehicles for utility companies, broadcast news vehicles, and other technical vehicles. It also offers service and maintenance, including mobile support and repairs on-call or under service contracts to help minimize vehicle downtime.
https://finance.yahoo.com/news/positiveid-e-n-g-mobile-120000995.html
PJET - MJ Merger just had a $100,000 bid!
$PSID Announces Highlights for the Third Quarter of 2017
https://finance.yahoo.com/news/positiveid-announces-highlights-third-quarter-120000443.html
VCST .008 Last 1, High of Year, $321,000 PROFITS!!!
ARYC is a Silicon Valley biotech trading at .009 and is on a 1 year uptrend and the fact remains, what is causing the PPS to climb is a litany of factual positive turns the company has manifested:
1. They have cured their cash-flow issues that precipitated the investor/lender crisis
2. The company has managed to grow their global sales to a constant impressive level affording the financial capacity to expand their technology based products and services
3. Because of the forward effort to repair the internal reportable financial structure, the company has put forth information, through the social network approved for said dissemination of information to the public, making themselves viewable by the investment industry. As a function of business, the world investor pool will take note and accordingly perform DD and without haste invest
4. No level of complaining or criticizing of the lack of financials at this point will neither accelerate the filing or discourage potential investors to take action
"The die is cast" when it comes to the fins; they are imminently coming sooner than later and they will confirm and add to the amazing growth of this company
I say congrats to those of us who did our DD and are standing to watch the fireworks coming...GLTA
$TRON Zero Dilution, No Reverse Split, and Extremely Low Float!!!
$TRON Share Structure 9/29/2017
Authorized: 850,000,000
Issued: 813,659,316
Restricted: 514,570,000
$DATI Purchases An Equity Stake in Cannabis Crowd Funding Company, Fundanna, Inc.
https://globenewswire.com/news-release/2017/08/23/1091665/0/en/Digital-Arts-Media-Network-Inc-Purchases-An-Equity-Stake-in-Cannabis-Crowd-Funding-Company-Fundanna-Inc.html
$DATI ~ Vezt, Inc. is the creator of a blockchain based music royalty sharing app.
They are the first company to leverage DATI's Angels+ accelerator program.
$TGGI MASSIVE RUN APPROACHING! RECENT PR RELEASE WITH HUGE UPDATES!
-Net Income $381,794.54 per 3rd Qtr Report (Confirmed)
-Already Eyeing Distribution Partners In Reno (In the works)
-Initial Funding for Cannabis Consortium to be in place in October 2017 with investors already lined up. (In The Works)
-TGGI owns 90% of Cannabis (Confirmed)
-TGGI will retain ownership of over 50% of Cannabis after Reg-A Filing (Confirmed - Pending Reg A)
-50% of Income of Cannabis goes to TGGI (Confirmed Upon Reg-A Completion)
-Massive Share Reduction On O/S. A/S. Float (Confirmed)
-2 BILLION Share Reduction of O/S/Float (In the works)
-TA Is Not Gagged (Confirmed)
-OTC Pink Current (Confirmed)
-No Debt of Any Kind (Confirmed)
-No Dilution (Confirmed)
-No Chance of R/S (Confirmed)
-Transparent CEO (Confirmed)
-4 Audited Revenue Streams Set Up (Confirmed upon Reg-A completion and distributions)
-Business in multiple states such as CO, FL, CA and DE (1/2 in the works 1/2 complete)
-CO Office Open in January 2018 (In the works)
-New FL Corporate OFfice Will Be Ready for Occupancy December 1st 2017 (In The Works)
-Licence deals (In the Works)
-MJ Industry (Confirmed)
-MMJ industry for animals (In the Works)
$PMCB Global Influenza Vaccination Market Research Report 2017 Analysis and Forecast to 2022 PMCB
Friday, September 29th, 2017 - Market Research Future
Market Research Future published new report, titled “Pancreatic cancer Market -Research Report: Global Forecast to 2022”.
Market Synopsis for Global Pancreatic cancer Market:
Market Scenario:
Cancer starts when cells in the body begin to grow out of control. Pancreatic cancer starts when cells in the pancreas start to grow uncontrollably. It causes Symptoms like abdominal pain, weight loss, diarrhea, and jaundice. The tumor hinders the normal functioning of pancreas. The biggest risk factor for developing pancreatic cancer is smoking. To diagnose the cancer doctor will do a complete physical exam and history check and then blood, urine, and stool tests may be done.
Market for Pancreatic cancer is growing as there is an increase in the consumption of alcohol, smoking and change is lifestyle.
Segments:
Global Pancreatic cancer market has been segmented on the basis of type which comprise of endocrine pancreas cancer, exocrine pancreas cancer and others. On the basis of treatment type; market is segmented into; surgery, radiation therapy, chemotherapy and others. On the basis of end users; market is segmented as; hospital, clinics, research institutes and others.
Key players for global Pancreatic cancer market:
Some of the key players in this market are: PharmaCyte Biotech Inc. (US), OncoGenex Pharmaceuticals Inc., Oncolytics Biotech (Canada), DiffusionPharmaceuticals (US), Polaris Pharmaceuticals, Inc., Sun BioPharma, Inc., Midatech Pharma PLC (UK) and others.
https://www.newsmaker.com.au/news/342650/global-influenza-vaccination-market-research-report-2017-analysis-and-forecast-to-2022#.WdMH69OGPBI
$PSID ExcitePCR to launch RT pathogen detection system in 2018
https://www.foodqualitynews.com/Article/2017/10/11/ExcitePCR-targets-on-site-pathogen-detection-market
$PSID looking for a strong close to the week! ExcitePCR to launch RT pathogen detection system in 2018 https://www.foodqualitynews.com/Article/2017/10/11/ExcitePCR-targets-on-site-pathogen-detection-market
$DATI Digital Arts Media Network First Angels+ Venture, Vezt Inc. Appears On Cheddar Financial News for Music Royalty Sharing App
https://finance.yahoo.com/news/digital-arts-media-network-first-225424590.html $BITCF $BTCS $GAHC $HSHS
$EPAZ Products include: MSHealth: A cloud based healthcare solution that integrates billing, scheduling, reports, imaging, and interactive forms. The workflow management and ePrescription features do much of the work for you while aligning with medical care guidelines.
$GFOO BREAKOUT ALERT! $GFOO WATCH THIS ONE! JUST RECEIVED NEVADA REINSTATEMENT, JUST GOT A NEW CEO WHO IS THE INVENTOR OF SOME HUGE PATENTS AND ALSO RUNS ANOTHER COMPANY WORTH $1.5 BILLION.
PATENTS OWNED/INVENTED BY NEW CEO
https://patents.justia.com/inventor/ching-ming-hsu
Ching Ming Hsu
https://www.bloomberg.com/profiles/people/20139385-ming-hsu-ching ; ;
THEY JUST HIRED A REVERSE MERGER ATTORNEY LAW FIRM.
Looks like they will have a Reverse Merger into what was previously an INACTIVE SHELL.
* They just Received "REINSTATEMENT" FROM NVSOS
* NEW CEO in AUGUST 2017
* HIRED NEW LAW FIRM THAT HANDLES REVERSE MERGERS
* CONFIRMED WITH ATTORNEY - TO WATCH FOR FILINGS AS THE COMPANY IS LOOKING
TO BECOME CURRENT
http://deanlawcorp.com/home.html
http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=qDpp60ra6IvRyjUMURZhug%253d%253d&CorpName=GENUFOOD+ENERGY+ENZYMES+CORP.
https://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12216648
$EPAZ Epazz unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet.
$EPAZ Thou must check it out for thyself here: http://www.otcmarkets.com/stock/EPAZ/quote
$EPAZ Products include: Provitrac: An applicant tracking solution to make finding, selecting and hiring employees easy. From job posting to an employee’s first day on the job, Provitrac gives you the tools to make strong decisions and strengthen your organization.
$EPAZ Products include: Jadian: A quality assurance suite that manages any compliance concerns your business may have. One feature is a web-based solution for enforcement bodies to electronically manage compliance, audits, inspections, licenses and certifications. Other features include the ability for executives and managers to automate and monitor compliance, inspections and preventative measures.
$EPAZ Products include: Intellisys: An integrated plant management software suite with four independent elements. EnergyView monitors and optimizes energy use. SystemView provides a viewing interface. ReportView organizes equipment, space, and work functions. MaintainenceView monitors needed equipment maintenance. Together or separately these applications monitor and streamline industrial facility functions.
$EPAZ have been consistently acquiring new software to expand their available services and meet the needs of more businesses.
Thou can view past News on $EPAZ hither
http://finance.yahoo.com/q?s=EPAZ
$EPAZ 2015 first quarter revenue increased by 83%
(http://finance.yahoo.com/news/epazz-reports-83-percent-increase-121500054.html)
Conglomerates: Cash Cows Or Corporate Chaos?
Conglomerates are companies that either partially or fully own a number of other companies. Not long ago, sprawling conglomerates were a prominent feature of the corporate landscape. Vast empires, such as General Electric (NYSE:GE) and Berkshire Hathaway (NYSE:BRK.A), were built up over many years with interests ranging from jet engine technology to jewelry. Corporate hodgepodges like these pride themselves on their ability to avoid bumpy markets. In some cases, they have produced impressive long-term shareholder returns - but this doesnt mean that corporate conglomerates are always a good thing for investors. If youre interested in investing in these behemoths, there are a few things you should know. Here we explain what conglomerates are and give you an overview of the pros and cons of investing in them.
The Case for Conglomerates
The case for conglomerates can be summed up in one word: diversification. According to financial theory, because the business cycle affects industries in different ways, diversification results in a reduction of investment risk. A downturn suffered by one subsidiary, for instance, can be counterbalanced by stability, or even expansion, in another venture. In other words, if Berkshire Hathaways brick-making division has a bad year, the loss might be offset by a good year in its insurance business.
At the same time, a successful conglomerate can show consistent earnings growth by acquiring companies whose shares are more lowly rated than its own. In fact, GE and Berkshire Hathaway have both promised - and delivered - double-digit earnings growth by applying this investment growth strategy.
The Case Against Conglomerates
However, the prominent success of conglomerates such as GE and Berkshire Hathaway is hardly proof that conglomeration is always a good idea. There are plenty of reasons to think twice about investing in these stocks , particularly in 2009, when both GE and Berkshire suffered as a result of the economic downturn, proving that size does not make a company infallible.
Investment guru Peter Lynch uses the phrase diworsification to describe companies that diversify into areas beyond their core competencies. A conglomerate can often be an inefficient, jumbled affair. No matter how good the management team, its energies and resources will be split over numerous businesses, which may or may not be synergistic.
For investors, conglomerates can be awfully hard to understand, and it can be a challenge to pigeonhole these companies into one category or investment theme. This means that even managers often have a hard time explaining their investment philosophy to shareholders. Furthermore, a conglomerates accounting can leave a lot to be desired and can obscure the performance of the conglomerates separate divisions. Investors inability to understand a conglomerates philosophy, direction, goals and performance can eventually lead to share underperformance.
While the counter-cyclical argument holds, there is also the risk that management will keep hold of businesses with poor performance, hoping to ride the cycle. Ultimately, lower-valued businesses prevent the value of higher-valued businesses from being fully realized in the share price . (For further reading, see The Ups And Downs Of Investing In Cyclical Stocks.)
Whats more, conglomerates do not always offer investors an advantage in terms of diversification. If investors want to diversity risk, they can do so by themselves, by investing in a few focused companies rather than putting all of their money into a single conglomerate. Investors can do this far more cheaply and efficiently than even the most acquisitive conglomerate can.
The Conglomerate Discount
The case against conglomerates is a strong one. Consequently, the market usually applies a haircut to the piecewise, or sum-of-parts, value - that is, it frequently values conglomerates at a discount to more focused companies. This is known as the conglomerate discount. According to a 2001 article in CFO Magazine, academic studies have suggested in the past that this discount could be as much as 10-12%, but more recent academic inquiries have concluded that the discount is closer to 5%. Of course, there are some conglomerates that command a premium but, in general, the market ascribes a discount.
The conglomerate discount gives investors a good idea of how the market values the conglomerate as compared to the sum value of its various parts. A deep discount signals that shareholders would benefit if the company were dismantled and its divisions left to run as separate stocks.
Lets take a shot at calculating the conglomerate discount using a simple example. Well use a fictional conglomerate called DiversiCo, which consists of two unrelated businesses: a beverage division and a biotechnology division.
DiversiCo has a stock market valuation of $2 billion and total debt of $0.75 billion. Its beverage division has balance sheet assets of $1 billion, while its biotechnology division has $0.75 billion worth of assets. Focused companies in the beverage industry have median market-to-book values of 2.5, while pure play biotech firms have market-to-book values of 2. DiversiCos divisions are fairly typical companies in their industries. From this information, we can calculate the conglomerate discount:
Example - Calculating the Conglomerate Discount
Total Market Value DiversiCo:
= Equity Debt
= $2 billion $0.75 billion
= $2.75 billion
Estimated Value Sum of the Parts:
= Value of Biotech Division Value of Beverage Division
= ($0.75 billion X 2) ($1 billion X 2.5)
= $1.5 billion $2.5 billion
= $4.0 billion
So, the conglomerate discount amounts to:
= ($4.0 billion - $2.75 billion)/$4.0 billion
= 31.25%
Copyright ??2009 Investopedia.com
DiversiCos conglomerate discount of 31.25% seems unusually deep. Its share price does not reflect the true value of its separate divisions. It becomes clear that this multibusiness company could be worth significantly more if it were broken up into individual businesses. Consequently, investors may push for divesting or spinning off its beverage and biotech divisions to create more value. If that were to happen, Diversico might be worth closer examination as a buying opportunity.
What to Look For
The big question is whether investing in conglomerates makes sense. The conglomerate discount suggests it does not. But there may be a silver lining. If you invest in conglomerates that break up into individual pieces through divestitures and spinoffs, you could capture an increase in value as the conglomerate discount disappears. As a general rule, you stand to get greater returns when conglomerates break up than when they are built.
That said, some conglomerates do command a valuation premium - or at least a slim conglomerate discount. These are extremely well-run companies. They are managed aggressively, with clear targets set for divisions. Underperforming companies are quickly sold, or divested. More importantly, successful conglomerates have financial rather than strategic or operating objectives, adopting strict approaches to portfolio management .
If you choose to invest in conglomerates, look for ones with financial discipline, rigorous analysis and valuation, a refusal to overpay for acquisitions and a willingness to sell off existing businesses. As with any investment decision , think before you buy and dont assume that big companies always come with big returns.
Feast thine eyes upon $PEMC BarChart Technical Analysis NITE-LYNX
http://www.barchart.com/technicals/stocks/PEMC
FINRA may halt trading and quotations in OTC Equity Securities in very limited circumstances where FINRA determines it is necessary to protect investors and the public interest. FINRA will exercise this authority only when 1) the OTC Equity Security or the security underlying an OTC ADR is halted on either a U.S. exchange or a foreign securities exchange or when FINRA determines that an extraordinary event has occurred that has a material effect on the market or may cause major disruption to the marketplace and/or significant uncertainty in the settlement and clearance process.
Resistance breaks and new highs indicate buyers have increased their expectations and are willing to buy at even higher prices.
Feast thine eyes upon $EDIG BarChart Technical Analysis NITE-LYNX
http://www.barchart.com/technicals/stocks/EDIG
5 Common Mistakes Young Investors Make
When learning any skill, it is best to start young. Investing is no different. Missteps are common when learning something new, but when dealing with money, they can have serious consequences. Investors who start young generally have the flexibility and time frame to take on risk and recover from their money-losing errors, but sidestepping the following common mistakes can help improve the odds of success. (In addition to this article, read Eight Financial Tips For Young Adults.)
1. Procrastinating
Procrastination is never good, but it can be especially detrimental while investing because the markets move so quickly. Good investment ideas are not always easy to find. If, after doing research, a good investment idea arises, it is important to act on it before the rest of the market takes note and beats you to it. Young investors can be prone to not acting on a good idea out of fear or inexperience. Missing out on a good idea can lead a young investor to two very bad scenarios:
1. The investor will revise his opinion upward and still purchase an asset when it is not warranted. Perhaps the investor rightly develops an opinion that an asset priced at $25 should be worth $50. If it moves up to $50 before he or she buys it, the investor may artificially revise the price target to $60 in order to rationalize the purchase.
2. The young investor will look for a replacement. In the previous example, the investor who failed to buy the asset that rose from $25 to $50 may quickly try to identify the next asset that will double. As a result, the investor might purchase another asset quickly, without doing the proper work and research, in order to try to make up for the previous missed opportunity. (Young investors often find themselves with too many options and not enough money. Read more in Competing Priorities: Too Many Choices, Too Few Dollars.)
2. Speculating Instead of Investing
A young investor is at an advantage in his or her investing life. Holding the level of wealth constant, an investors age affects how much risk an he or she can take on. So, a young investor can seek out bigger returns by taking bigger risks. This is because if a young investor loses money, he or she has time to recover the losses through income generation. This may seem like an argument for a young investor to speculate, but it is not.
Any young or novice investor will have an inclination to speculate if they do not fully understand the investment process. Speculation is often the equivalent of gambling, as the speculator does not necessarily have a reason for a purchase except that there is a chance that it may go up in value. This can be dangerous, as there are many experienced professionals waiting to take advantage of their less-experienced counterparts.
Instead of speculating and gambling, a young investor should look to invest in companies that have higher risk but greater upside potential over the long term. So, while a diversified portfolio of small-cap growth stocks would not be appropriate for an investor nearing retirement, a young investor is better equipped to take on that risk and can take advantage accordingly.
A final risk of speculation is that a large loss can scar a young investor and affect his or her future investment choices. This can lead to a tendency to shun investing altogether or to move to lower or risk-free assets at an age when it may not be appropriate. (For more insight, seePersonalizing Risk Tolerance.)
3. Using Too Much Leverage
Leverage has its benefits and its pitfalls. If there is ever a time when investors have the ability to add leverage to their portfolios, it is when they are young. As mentioned earlier, young investors have a greater ability to recover from losses through future income generation. However, similar to speculation, leverage can shatter even a good portfolio.
If a young investor is able to stomach a 20-25% drop in his or her portfolio without getting discouraged, the 40-50% drop that would result at two times leverage may be too much to handle. The consequences of such a drop are similar to those resulting from a loss due to speculation: the young investor may become discouraged and overly risk averse for the rest of his investing life. (Want to learn more about leverage? See Leverages Double-Edged Sword Need Not Cut Deep for more.)
4. Not Asking Enough Questions
If a stock drops a lot, a young investor might expect it to bounce right back, but more often than not, it is down for good reason. One of the most important factors in forming investment decisions is asking why. If an asset is trading at half of an investors perceived value, there is a reason and it is the investors responsibility to find it. Young investors who have not experienced the pitfalls of investing can be particularly susceptible to making decisions without locating all the pertinent information.
5. Not Investing
As mentioned earlier, an investor has the best ability to seek a higher return and take on higher risk when they have a long-term time horizon. Investors have their longest time horizons, and therefore a high tolerance for risk, when they are young. Young people also tend to be less experienced with having money. As a result, they are often tempted to focus on how money can benefit them in the present, without focusing on any long-term goals (such as retirement). Spending money now instead of saving and investing can create bad habits and contribute to a lack of savings and retirement funds. (For more on this, read Young Investors: What Are You Waiting For?)
The Bottom Line
Young investors should take advantage of their age and their increased ability to take on risk. Applying investing fundamentals early can help lead to a bigger portfolio later in life. There are also many risks that a young/less-experienced investor will face when making decisions. Hopefully, avoiding some of the common mistakes above will help young people learn investing early and embark on a fruitful investing career.
FINRA members publishing quotations in an inter-dealer quotation system must publish the price and full size of a customer order if that order improves or is equal to the member’s price. Exceptions exist for orders under minimum tier size, block orders and customer requests.
If a stock has already advanced significantly, it may be prudent to wait for a pullback. Or, if the stock is trending lower, it might pay to wait for buying interest and a trend reversal.
For thou convenience $FRGY BarChart Technical Analysis NITE-LYNX
http://www.barchart.com/technicals/stocks/FRGY
When a security is suspended or halted, OTC Markets removes all market participants and their quotes from the system and displays a "Halted/Suspended" message.
Followers
|
1492
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
821321
|
Created
|
03/04/10
|
Type
|
Free
|
Moderator PhotoChick | |||
Assistants Nilbud ManicTrader |
Posts Today
|
0
|
Posts (Total)
|
821321
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |